genedrive plc (AIM:GDR)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.8750
-0.1000 (-10.26%)
Nov 6, 2026, 4:41 PM GMT
genedrive Market Cap
genedrive has a market cap or net worth of 14.05 million as of November 6, 2026. It is the 37,149th most valuable company in the world and the 803rd biggest in the United Kingdom. Its market cap has increased by 45.93% in one year.
Market Cap
14.05M
Enterprise Value
14.16M
Revenue
1.17M
Global Rank
Country Rank
#803 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since April 10, 2007, genedrive's market cap has increased from 11.67M to 14.05M, an increase of 20.38%. That is a compound annual growth rate of 0.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 14.05M | 55.94% |
| Dec 31, 2025 | 9.01M | -32.30% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.79B |
| GSK plc | 75.77B |
| Haleon | 30.01B |
| Smith & Nephew | 9.90B |
| Provexis | 20.06M |
| ImmuPharma | 18.79M |
| RUA Life Sciences | 16.76M |
| Inspiration Healthcare Group | 15.69M |